An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Clinical trial NCT01863238 · COMPLETED
Trial details
- NCT number
- NCT01863238
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-05-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.